AUGX
Income statement / Annual
Last year (2023), Augmedix, Inc.'s total revenue was $44.86 M,
an increase of 45.01% from the previous year.
In 2023, Augmedix, Inc.'s net income was -$19.17 M.
See Augmedix, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$44.86 M |
$30.93 M |
$22.17 M |
$16.48 M |
$14.11 M |
$10.82 M |
| Cost of Revenue |
$23.33 M
|
$16.98 M
|
$12.16 M
|
$9.69 M
|
$9.43 M
|
$10.03 M
|
| Gross Profit |
$21.53 M
|
$13.95 M
|
$10.01 M
|
$6.79 M
|
$4.68 M
|
$785.92 K
|
| Gross Profit Ratio |
0.48
|
0.45
|
0.45
|
0.41
|
0.33
|
0.07
|
| Research and Development Expenses |
$11.18 M
|
$10.15 M
|
$6.68 M
|
$4.52 M
|
$6.98 M
|
$6.96 M
|
| General & Administrative Expenses |
$18.44 M
|
$16.89 M
|
$13.76 M
|
$11.57 M
|
$10.86 M
|
$13.15 M
|
| Selling & Marketing Expenses |
$10.69 M
|
$9.28 M
|
$7.51 M
|
$4.40 M
|
$3.58 M
|
$3.59 M
|
| Selling, General & Administrative Expenses |
$29.13 M
|
$26.18 M
|
$21.27 M
|
$15.97 M
|
$14.44 M
|
$16.75 M
|
| Other Expenses |
$0.00
|
$0.00
|
$87.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$40.31 M
|
$36.33 M
|
$27.95 M
|
$20.49 M
|
$21.42 M
|
$22.87 M
|
| Cost And Expenses |
$63.63 M
|
$53.30 M
|
$40.10 M
|
$30.18 M
|
$30.85 M
|
$32.90 M
|
| Interest Income |
$1.11 M
|
$245.00 K
|
$15.00 K
|
$10.84 K
|
$6.27 K
|
$2.08 M
|
| Interest Expense |
$2.25 M
|
$1.68 M
|
$2.25 M
|
$1.45 M
|
$2.81 M
|
$0.00
|
| Depreciation & Amortization |
$1.10 M
|
$1.53 M
|
$691.00 K
|
$867.00 K
|
$949.01 K
|
$1.59 M
|
| EBITDA |
-$15.68 M |
-$21.81 M |
-$14.47 M |
-$13.28 M |
-$14.74 M |
-$21.33 M |
| EBITDA Ratio |
-0.35
|
-0.7
|
-0.65
|
-0.81
|
-1.04
|
-1.97
|
| Operating Income Ratio |
-0.42
|
-0.72
|
-0.81
|
-0.83
|
-1.19
|
-2.12
|
| Total Other Income/Expenses Net |
-$247.00 K
|
-$1.97 M
|
$134.00 K
|
-$1.91 M
|
-$1.76 M
|
-$1.24 M
|
| Income Before Tax |
-$19.03 M
|
-$24.45 M
|
-$17.85 M
|
-$15.60 M
|
-$18.50 M
|
-$24.16 M
|
| Income Before Tax Ratio |
-0.42
|
-0.79
|
-0.81
|
-0.95
|
-1.31
|
-2.23
|
| Income Tax Expense |
$145.00 K
|
$0.00
|
-$691.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$19.17 M
|
-$26.53 M
|
-$17.16 M
|
-$14.74 M
|
-$22.36 M
|
-$24.16 M
|
| Net Income Ratio |
-0.43
|
-0.86
|
-0.77
|
-0.89
|
-1.59
|
-2.23
|
| EPS |
-0.44 |
-0.71 |
-0.59 |
-0.56 |
-26.89 |
-12.25 |
| EPS Diluted |
-0.44 |
-0.71 |
-0.59 |
-0.55 |
-26.89 |
-12.25 |
| Weighted Average Shares Out |
$43.95 M
|
$37.42 M
|
$28.91 M
|
$26.25 M
|
$831.59 K
|
$1.97 M
|
| Weighted Average Shares Out Diluted |
$43.95 M
|
$37.42 M
|
$28.91 M
|
$26.86 M
|
$831.59 K
|
$1.97 M
|
| Link |
|
|
|
|
|
|
